Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapyF Ciardiello, T Troiani, R Bianco, et al.
International Journal of Cancer|June 19, 2001
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell linesF Ciardiello, R Caputo, T Troiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitorsM P Morelli, T Cascone, T Troiani, et al.
British Journal of Cancer|July 14, 2011
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitorsF Morgillo, T Cascone, E D'Aiuto, et al.
Cancer Treatment Reviews|April 2, 2021
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trialsE F Giunta, G Bregni, A Pretta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectivesE Martinelli, D Ciardiello, G Martini, et al.
British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trialN Normanno, A M Rachiglio, M Lambiase, et al.
European Review for Medical and Pharmacological Sciences|April 25, 2020
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumorsA Ronchi, M Montella, I Cozzolino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical researchC Marchiò, M Scaltriti, M Ladanyi, et al.
Pageof 5